Bausch & Lomb is a major Canadian eye health products company based in Vaughan, Ontario. The firm operates globally as one of the world's largest suppliers of contact lenses, intraocular lenses, and comprehensive eye care pharmaceuticals.
Subscribe to see Bausch & Lomb’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Bausch & Lomb is a healthcare company headquartered in United States. Its most recent funding round, Series A, raised $31M in August 2007. Xcout tracks 2 named people at Bausch & Lomb, including Brent Saunders (CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $31M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Bausch & Lomb's closest competitors — see the full list of competitors and alternatives →
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.
The Toronto office of Johnson & Johnson is a corporate location situated in the Greater Toronto Area in cities such as Markham and Guelph, Ontario, Canada. It serves as a physical workplace for employees supporting the healthcare company's regional operations.
Santen Pharmaceutical Co., Ltd. is headquartered in Osaka, Japan, and is a global leader in ophthalmological research, development, production, and marketing of related pharmaceuticals and medical devices.
MediPrint Ophthalmics is a clinical-stage eye care pharmaceutical company that develops and commercializes a proprietary ocular drug delivery portfolio. The company provides drug-eluting, comfort-enhancing contact lenses designed to offer continuous medication delivery and vision correction for patients with ocular diseases.
Eyenovia, Inc. is a New York-based ophthalmic technology and pharmaceutical manufacturing company focused on targeted drug-delivery solutions for eye care using its proprietary Optejet device.
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.